Modified Antibiotic Adjuvant Ratios Can Slow and Steer the Evolution of Resistance: Co-amoxiclav as a Case Study

por Richard C. Allen, Sam P. Brown
Publicado 2019

Limiting damage during infection: lessons from infection tolerance for novel therapeutics.

por Pedro F Vale, Andy Fenton, Sam P Brown
Publicado 2014

Division of Labor, Bet Hedging, and the Evolution of Mixed Biofilm Investment Strategies

por Nick Vallespir Lowery, Luke McNally, William C. Ratcliff, Sam P. Brown
Publicado 2017

Evolving Antibiotics against Resistance: a Potential Platform for Natural Product Development?

por Kristofer Wollein Waldetoft, James Gurney, Joseph Lachance, Paul A. Hoskisson, Sam P. Brown
Publicado 2019

Killing by Type VI secretion drives genetic phase separation and correlates with increased cooperation

por Luke McNally, Eryn Bernardy, Jacob Thomas, Arben Kalziqi, Jennifer Pentz, Sam P. Brown, Brian K. Hammer, Peter J. Yunker, William C. Ratcliff
Publicado 2017